Lv1
20 积分 2023-04-18 加入
Evaluation of Short-to-medium Term Efficacy of Guselkumab and Secukinumab in Overweight and Obese Patients with Moderate to Severe Plaque Psoriasis: A 24-Week Single-center Retrospective Study
6天前
已完结
Effect of interleukin 23 inhibitors (risankizumab and guselkumab) on cardiovascular and cerebrovascular risk in psoriasis patients
6天前
已完结
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage
19天前
已完结
皖公网安备34019202002308
